These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37322408)

  • 1. Molecular and clinical characterization of PTRF in glioma via 1,022 samples.
    Sun S; Yang C; Wang K; Huang R; Zhang KN; Liu Y; Cao Z; Zhao Z; Jiang T
    BMC Cancer; 2023 Jun; 23(1):551. PubMed ID: 37322408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas.
    Guan X; Zhang C; Zhao J; Sun G; Song Q; Jia W
    EBioMedicine; 2018 Sep; 35():233-243. PubMed ID: 30131308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.
    Yi K; Cui X; Liu X; Wang Y; Zhao J; Yang S; Xu C; Yang E; Xiao M; Hong B; Fang C; Kang C; Tan Y; Wang Q
    Front Immunol; 2021; 12():802795. PubMed ID: 35069587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Characterization and Clinical Relevance of
    Qian Z; Fan W; Meng F; Sun Z; Li G; Zhai Y; Chang Y; Yang C; Zeng F; Chai R; Wu F; Zhao Z
    Front Cell Dev Biol; 2021; 9():777182. PubMed ID: 34912807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.
    Yi K; Zhan Q; Wang Q; Tan Y; Fang C; Wang Y; Zhou J; Yang C; Li Y; Kang C
    Neuro Oncol; 2021 Mar; 23(3):387-399. PubMed ID: 33140095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
    Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
    Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
    Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
    Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Genomic and Transcriptomic Analysis of Primary Malignant Gliomas Revealed Different Patterns Between Grades and Somatic Mutations Related to Glioblastoma Prognosis.
    Jin H; Yu Z; Tian T; Shen G; Chen W; Fan M; He Q; Dai D; Zhang X; Liu D
    Front Mol Biosci; 2022; 9():873042. PubMed ID: 35865002
    [No Abstract]   [Full Text] [Related]  

  • 9. PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
    Yeh HC; Margulis V; Singla N; Hernandez E; Panwar V; Woldu SL; Karam JA; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Li CC; Ke HL; Li WM; Lee HY; Rapoport LM; Lotan Y; Kapur P; Shariat SF; Hsieh JT; Wu WJ
    Urol Oncol; 2020 May; 38(5):496-505. PubMed ID: 31862213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTRF suppresses the progression of colorectal cancers.
    Wang F; Zheng Y; Orange M; Yang C; Yang B; Liu J; Tan T; Ma X; Chen T; Yin X; Tang X; Zhu H
    Oncotarget; 2017 Jul; 8(30):48650-48659. PubMed ID: 27203393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
    Zhao Y; Wang Y; Zhao E; Tan Y; Geng B; Kang C; Li X
    Carcinogenesis; 2020 May; 41(3):274-283. PubMed ID: 31605605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding the transcriptome of muscular dystrophy due to Ptrf deficiency using single-nucleus RNA sequencing.
    Li X; Zhong Z; Zhang R; Zhang J; Zhang Y; Zeng S; Du Q; Wang H; Zhang S; Lu L; Li M; Long K
    FASEB J; 2023 Jun; 37(6):e22993. PubMed ID: 37235502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor mutational burden is associated with poor outcomes in diffuse glioma.
    Wang L; Ge J; Lan Y; Shi Y; Luo Y; Tan Y; Liang M; Deng S; Zhang X; Wang W; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Mar; 20(1):213. PubMed ID: 32164609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.
    Cen X; Chen Q; Wang B; Xu H; Wang X; Ling Y; Zhang X; Qin D
    Cell Commun Signal; 2022 Nov; 20(1):191. PubMed ID: 36443833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
    Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
    Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
    Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.
    Meng F; Joshi B; Nabi IR
    PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.